Summit Therapeutics plc (SMMT) PT Raised to $50 at H.C. Wainwright, 'Time to own SMMT'
Tweet Send to a Friend
H.C. Wainwright analyst Mitchell S. Kapoor raised the price target on Summit Therapeutics plc (NASDAQ: SMMT) to $50.00 (from $44.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
